| The 2016 World Health Organization classification of tumors of the central nervous system: a summary DN Louis, A Perry, G Reifenberger, A Von Deimling, D Figarella-Branger, ... Acta neuropathologica 131 (6), 803-820, 2016 | 9707 | 2016 |
| I nternational S ociety of N europathology‐H aarlem C onsensus G uidelines for N ervous S ystem T umor C lassification and G rading DN Louis, A Perry, P Burger, DW Ellison, G Reifenberger, A von Deimling, ... Brain pathology 24 (5), 429-435, 2014 | 526 | 2014 |
| New brain tumor entities emerge from molecular classification of CNS-PNETs D Sturm, BA Orr, UH Toprak, V Hovestadt, DTW Jones, D Capper, M Sill, ... Cell 164 (5), 1060-1072, 2016 | 502 | 2016 |
| OPA1 mutations induce mitochondrial DNA instability and optic atrophy ‘plus’ phenotypes P Amati-Bonneau, ML Valentino, P Reynier, ME Gallardo, B Bornstein, ... Brain 131 (2), 338-351, 2008 | 483 | 2008 |
| Central neurocytoma: a synopsis of clinical and histological features J Hassoun, F Söylemezoglu, D Gambarelli, D Figarella‐Branger, ... Brain Pathology 3 (3), 297-306, 1993 | 349 | 1993 |
| A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case–control study of 410 patients with 8 years post-operative follow-up J Trouillas, P Roy, N Sturm, E Dantony, C Cortet-Rudelli, G Viennet, ... Acta neuropathologica 126 (1), 123-135, 2013 | 315 | 2013 |
| Pilocytic astrocytomas in children: prognostic factors—a retrospective study of 80 cases C Fernandez, D Figarella-Branger, N Girard, C Bouvier-Labit, J Gouvernet, ... Neurosurgery 53 (3), 544-555, 2003 | 291 | 2003 |
| Macrophagic myofasciitis: an emerging entity RK Gherardi, M Coquet, P Chérin, FJ Authier, P Laforêt, L Belec, ... The Lancet 352 (9125), 347-352, 1998 | 288 | 1998 |
| Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis S Rutkowski, K Von Hoff, A Emser, I Zwiener, T Pietsch, ... Journal of clinical oncology 28 (33), 4961-4968, 2010 | 278 | 2010 |
| Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis P Metellus, B Coulibaly, C Colin, AM de Paula, A Vasiljevic, D Taieb, ... Acta neuropathologica 120 (6), 719-729, 2010 | 276 | 2010 |
| Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial B Lannering, S Rutkowski, F Doz, B Pizer, G Gustafsson, A Navajas, ... Journal of clinical oncology 30 (26), 3187-3193, 2012 | 262 | 2012 |
| Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes K Nguyen, G Bassez, M Krahn, R Bernard, P Laforêt, V Labelle, ... Archives of neurology 64 (8), 1176-1182, 2007 | 243 | 2007 |
| Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA C Huxley, E Passage, A Manson, G Putzu, D Figarella-Branger, ... Human molecular genetics 5 (5), 563-569, 1996 | 237 | 1996 |
| Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts DW Ellison, M Kocak, D Figarella-Branger, G Felice, G Catherine, ... Journal of negative results in biomedicine 10 (1), 1-13, 2011 | 231 | 2011 |
| Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide OL Chinot, M Barrie, S Fuentes, N Eudes, S Lancelot, P Metellus, ... Journal of Clinical Oncology 25 (12), 1470-1475, 2007 | 228 | 2007 |
| Pineal region tumors and the role of stereotactic biopsy: review of the mortality, morbidity, and diagnostic rates in 370 cases J Regis, P Bouillot, F Rouby-Volot, D Figarella-Branger, H Dufour, ... Neurosurgery 39 (5), 907-914, 1996 | 228 | 1996 |
| Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience G Raverot, N Sturm, F De Fraipont, M Muller, S Salenave, P Caron, ... The Journal of Clinical Endocrinology & Metabolism 95 (10), 4592-4599, 2010 | 221 | 2010 |
| Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease S Bilodeau, S Vallette-Kasic, Y Gauthier, D Figarella-Branger, T Brue, ... Genes & development 20 (20), 2871-2886, 2006 | 221 | 2006 |
| Recurrent mutations of MYD88 and TBL1XR1 in primary central nervous system lymphomas A Gonzalez-Aguilar, A Idbaih, B Boisselier, N Habbita, M Rossetto, ... Clinical cancer research 18 (19), 5203-5211, 2012 | 214 | 2012 |
| Stereoelectroencephalography in presurgical assessment of MRI-negative epilepsy A McGonigal, F Bartolomei, J Régis, M Guye, M Gavaret, ATD Fonseca, ... Brain 130 (12), 3169-3183, 2007 | 212 | 2007 |
